$GBLX
GB SCIENCES INC Stock $gblx

$gblx Overview Financials Valuation SEC Filings Company Website

2020 Q3 Form 10-K Financial Statement

#000143774920018953 Filed on August 28, 2020

Income Statement

Concept	2020 Q3	2020	2019 Q1
Revenue	$0.00		$726.3K
YoY Change			-17.47%
Cost Of Revenue	$0.00		$2.060M
YoY Change			795.75%
Gross Profit	$0.00		-$1.334M
YoY Change			-305.22%
Gross Profit Margin			-183.67%
Selling, General & Admin	$491.8K	$5.742M	$3.787M
YoY Change	-61.91%	-57.15%	-44.14%
% of Gross Profit
Research & Development		$1.543M
YoY Change		236.41%
% of Gross Profit
Depreciation & Amortization	$2.580K	$541.5K	$233.2K
YoY Change	-102.13%	60.11%	16.58%
% of Gross Profit
Operating Expenses	$491.8K	$1.543M	$3.787M
YoY Change	-61.91%	236.41%	-44.06%
Operating Profit	-$491.8K	-$5.742M	-$5.121M
YoY Change	-61.91%	-56.47%	-16.32%
Interest Expense	$410.9K	$1.109M	-$321.1K
YoY Change	16.5%	-77.55%	-90.15%
% of Operating Profit
Other Income/Expense, Net	-$412.7K	$992.5K	-$16.24K
YoY Change	58.71%	-111.94%	-96.82%
Pretax Income	-$904.5K	-$4.749M	-$5.459M
YoY Change	-41.69%	-77.91%	-44.86%
Income Tax	$0.00		-$211.4K
% Of Pretax Income
Net Earnings	-$805.5K	-$12.37M	-$4.983M
YoY Change	-69.98%	-47.69%	-49.05%
Net Earnings / Revenue			-686.09%
Basic Earnings Per Share
Diluted Earnings Per Share	-$2.871K	-$47.88K	-$21.18K
COMMON SHARES
Basic Shares Outstanding	280.5M
Diluted Shares Outstanding

Balance Sheet

Concept	2020 Q3	2020	2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$545.0K	$151.8K	$227.8K
YoY Change	542.71%	-33.36%	-93.64%
Cash & Equivalents	$545.0K	$151.8K	$182.1K
Short-Term Investments
Other Short-Term Assets	$2.016M	$60.89K	$614.2K
YoY Change	31.17%	-90.09%	-68.66%
Inventory		$1.446M	$1.534M
Prepaid Expenses			$300.0K
Receivables		$118.0K	$488.3K
Other Receivables		$5.224M	$0.00
Total Short-Term Assets	$6.911M	$7.001M	$3.467M
YoY Change	106.27%	101.94%	-52.18%
LONG-TERM ASSETS
Property, Plant & Equipment	$31.28K	$5.561M	$10.48M
YoY Change	-99.7%	-76.34%	-23.82%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$5.767M	$91.50K	$1.233M
YoY Change	-59.07%	-92.58%	-24.35%
Total Long-Term Assets	$7.343M	$7.352M	$26.56M
YoY Change	-72.28%	-72.32%	58.07%
TOTAL ASSETS
Total Short-Term Assets	$6.911M	$7.001M	$3.467M
Total Long-Term Assets	$7.343M	$7.352M	$26.56M
Total Assets	$14.25M	$14.35M	$30.02M
YoY Change	-52.23%	-52.19%	24.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.347M	$2.560M	$1.375M
YoY Change	44.73%	-16.64%	271.56%
Accrued Expenses	$1.205M	$1.879M	$244.9K
YoY Change	61.11%	210.41%	-50.01%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$151.9K	$0.00
YoY Change
Long-Term Debt Due	$6.428M	$5.702M	$2.530M
YoY Change	27.95%	125.37%	138.66%
Total Short-Term Liabilities	$13.14M	$10.89M	$6.712M
YoY Change	39.4%	62.18%	249.59%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$3.533M	$6.155M
YoY Change	-100.0%	-42.6%	-5.31%
Other Long-Term Liabilities	$3.465M	$22.52K
YoY Change	41.47%
Total Long-Term Liabilities	$3.465M	$3.556M	$6.155M
YoY Change	-43.19%	-42.23%	-5.31%
TOTAL LIABILITIES
Total Short-Term Liabilities	$13.14M	$10.89M	$6.712M
Total Long-Term Liabilities	$3.465M	$3.556M	$6.155M
Total Liabilities	$16.60M	$14.44M	$12.87M
YoY Change	-32.38%	-33.52%	13.87%
SHAREHOLDERS EQUITY
Retained Earnings	-$100.1M		-$84.74M
YoY Change
Common Stock	$28.05K		$24.06K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$2.350M	-$88.49K	$17.16M
YoY Change
Total Liabilities & Shareholders Equity	$14.25M	$14.35M	$30.02M
YoY Change	-52.23%	-52.19%	24.84%

Cashflow Statement

Concept	2020 Q3	2020	2019 Q1
OPERATING ACTIVITIES
Net Income	-$805.5K	-$12.37M	-$4.983M
YoY Change	-69.98%	-47.69%	-49.05%
Depreciation, Depletion And Amortization	$2.580K	$541.5K	$233.2K
YoY Change	-102.13%	60.11%	16.58%
Cash From Operating Activities	$111.0K	-$4.480M	-$1.392M
YoY Change	-112.13%	-54.55%	-67.09%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$202.3K	-$9.438M
YoY Change	-100.0%	-86.62%	325.14%
Acquisitions
YoY Change
Other Investing Activities	$597.7K	-$244.6K	$7.899M
YoY Change	-329.32%	-97.3%	-564.64%
Cash From Investing Activities	$597.7K	-$538.8K	-$1.539M
YoY Change	-301.16%	-95.1%	-60.73%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$790.2K
YoY Change		-93.07%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-115.6K	4.988M	2.835M
YoY Change	-109.92%	-71.5%	-72.34%
NET CHANGE
Cash From Operating Activities	111.0K	-4.480M	-1.392M
Cash From Investing Activities	597.7K	-538.8K	-1.539M
Cash From Financing Activities	-115.6K	4.988M	2.835M
Net Change In Cash	593.0K	-30.29K	-96.29K
YoY Change	-1361.74%	-99.1%	-104.59%
FREE CASH FLOW
Cash From Operating Activities	$111.0K	-$4.480M	-$1.392M
Capital Expenditures	$0.00	$202.3K	-$9.438M
Free Cash Flow	$111.0K	-$4.682M	$8.046M
YoY Change	-112.63%	-58.81%	-500.3%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2020	dei	Entity Central Index Key EntityCentralIndexKey	0001165320
CY2020	dei	Entity Registrant Name EntityRegistrantName	GB SCIENCES INC
CY2020	dei	Amendment Flag AmendmentFlag	false
CY2020	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2020	gblx	Effective Income Tax Rate Reconciliation Irc Section280e Amount EffectiveIncomeTaxRateReconciliationIrcSection280eAmount	202877
CY2020	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2020	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020	dei	Document Period End Date DocumentPeriodEndDate	2020-03-31
CY2020	dei	Document Type DocumentType	10-K
CY2020Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	280532686
CY2020	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2020	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2019Q3	dei	Entity Public Float EntityPublicFloat	25500000
CY2020	dei	Entity Shell Company EntityShellCompany	false
CY2020	dei	Entity Small Business EntitySmallBusiness	true
CY2020	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2020	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2020	dei	Security12g Title Security12gTitle	Common Stock $.0001 Par Value
CY2020	dei	Trading Symbol TradingSymbol	gblx
CY2020	gblx	Adjustments To Additional Paid In Capital Induced Note Conversion AdjustmentsToAdditionalPaidInCapitalInducedNoteConversion	127059
CY2019	gblx	Asset Forfeiture Charge AssetForfeitureCharge	200000
CY2020	gblx	Cash Paid To Settle Royalty Agreement CashPaidToSettleRoyaltyAgreement
CY2019	gblx	Cash Paid To Settle Royalty Agreement CashPaidToSettleRoyaltyAgreement	1000000
CY2019	gblx	Class Of Warrant Or Right Cancelled During Period ClassOfWarrantOrRightCancelledDuringPeriod	1312500
CY2020	gblx	Class Of Warrant Or Right Cancelled During Period ClassOfWarrantOrRightCancelledDuringPeriod	5312608
CY2019	gblx	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	12657875
CY2020	gblx	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	17563000
CY2019	gblx	Class Of Warrant Or Right Issued During Period ClassOfWarrantOrRightIssuedDuringPeriod	47878302
CY2020	gblx	Class Of Warrant Or Right Issued During Period ClassOfWarrantOrRightIssuedDuringPeriod	7622780
CY2020	gblx	Class Of Warrant Or Right Issued During Period Exercise Price ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice	0.30
CY2019Q4	gblx	Consulting Expense Related To Common Stock Payments ConsultingExpenseRelatedToCommonStockPayments	180000
CY2020	gblx	Consulting Service Expense ConsultingServiceExpense	214000
CY2019	gblx	Consulting Service Expense ConsultingServiceExpense	900000
CY2020	gblx	Cumulative Effect Of New Lease Standard CumulativeEffectOfNewLeaseStandard	7550
CY2019	gblx	Cumulative Effect Of New Lease Standard CumulativeEffectOfNewLeaseStandard
CY2020	gblx	Depreciation Capitalized In Inventory DepreciationCapitalizedInInventory	811508
CY2019	gblx	Depreciation Capitalized In Inventory DepreciationCapitalizedInInventory	584017
CY2020	gblx	Depreciation Capitalized To Inventory DepreciationCapitalizedToInventory	811508
CY2019	gblx	Depreciation Capitalized To Inventory DepreciationCapitalizedToInventory	584017
CY2019	gblx	Effective Income Tax Rate Reconciliation Irc Section280e Amount EffectiveIncomeTaxRateReconciliationIrcSection280eAmount	968870
CY2020	gblx	Exercise Of Warrants For Stock Shares ExerciseOfWarrantsForStockShares	17563000
CY2019	gblx	Exercise Of Warrants For Stock Shares ExerciseOfWarrantsForStockShares	12657875
CY2019	gblx	Exercise Of Warrants For Stock Value ExerciseOfWarrantsForStockValue	3920720
CY2020	gblx	Exercise Of Warrants For Stock Value ExerciseOfWarrantsForStockValue	1157727
CY2020	gblx	Finance Lease Costs FinanceLeaseCosts	679347
CY2020	gblx	Property Capitalized Under Operating Leases PropertyCapitalizedUnderOperatingLeases	182624
CY2019	gblx	Property Capitalized Under Operating Leases PropertyCapitalizedUnderOperatingLeases
CY2020	gblx	Gain Loss On Modification Of Notes Receivable GainLossOnModificationOfNotesReceivable	-1895434
CY2019	gblx	Gain Loss On Modification Of Notes Receivable GainLossOnModificationOfNotesReceivable
CY2020	gblx	Income Tax Reconciliation Accrued Interest On Prior Year Tax Liabilities IncomeTaxReconciliationAccruedInterestOnPriorYearTaxLiabilities	47924
CY2020	gblx	Income Tax Reconciliation Prior Year Tax Penalties IncomeTaxReconciliationPriorYearTaxPenalties	38913
CY2019	gblx	Income Tax Reconciliation Prior Year Tax Penalties IncomeTaxReconciliationPriorYearTaxPenalties	15498
CY2020	gblx	Increase Decrease In Accrued Liabilities Excluding Interest Payable IncreaseDecreaseInAccruedLiabilitiesExcludingInterestPayable	707158
CY2019	gblx	Increase Decrease In Accrued Liabilities Excluding Interest Payable IncreaseDecreaseInAccruedLiabilitiesExcludingInterestPayable	38780
CY2020	gblx	Induced Dividend From Exercise Of Warrants InducedDividendFromExerciseOfWarrants	262240
CY2019	gblx	Induced Dividend From Exercise Of Warrants InducedDividendFromExerciseOfWarrants	2861436
CY2019	gblx	Induced Dividend From Warrant Exercises InducedDividendFromWarrantExercises
CY2020	gblx	Induced Dividend From Warrant Exercises InducedDividendFromWarrantExercises
CY2020	gblx	Interest Income Receivable And Amortization Of Discount On Note Receivable InterestIncomeReceivableAndAmortizationOfDiscountOnNoteReceivable	509265
CY2019	gblx	Interest Income Receivable And Amortization Of Discount On Note Receivable InterestIncomeReceivableAndAmortizationOfDiscountOnNoteReceivable
CY2020	gblx	Issuance Of Stock For Services IssuanceOfStockForServices	214000
CY2019	gblx	Issuance Of Stock For Services IssuanceOfStockForServices	1254363
CY2020	gblx	Issuance Of Warrants To Brokers IssuanceOfWarrantsToBrokers	132914
CY2019	gblx	Issuance Of Warrants To Brokers IssuanceOfWarrantsToBrokers	592638
CY2019Q4	gblx	Monthly Consulting Fee MonthlyConsultingFee	50000
CY2020	gblx	Operating Lease Interest Expense OperatingLeaseInterestExpense	27611
CY2020Q1	gblx	Operating Loss Carryforwards Not Subject To Expiration OperatingLossCarryforwardsNotSubjectToExpiration	16115818
CY2020Q1	gblx	Operating Loss Carryforwards Subject To Expiration OperatingLossCarryforwardsSubjectToExpiration	34481122
CY2020	gblx	Patent Filing And Drafting Costs Capitalized In Intangible Assets PatentFilingAndDraftingCostsCapitalizedInIntangibleAssets	247646
CY2019	gblx	Patent Filing And Drafting Costs Capitalized In Intangible Assets PatentFilingAndDraftingCostsCapitalizedInIntangibleAssets
CY2019Q4	gblx	Proceeds From Issuance Of Common Stock And Warrants ProceedsFromIssuanceOfCommonStockAndWarrants	240000
CY2019Q4	gblx	Quarterly Stock Fee Shares QuarterlyStockFeeShares	2000000
CY2020	gblx	Revenue Inculding Discontinued Operations RevenueInculdingDiscontinuedOperations	3689697
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	287260
CY2019	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	592638
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	158404020
CY2020	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	829737
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1966388
CY2019	gblx	Stock Issued To Settle Royalty Agreement Shares StockIssuedToSettleRoyaltyAgreementShares	600000
CY2019	gblx	Stock Issued To Settle Royalty Agreement Value StockIssuedToSettleRoyaltyAgreementValue	131000
CY2020	gblx	Stock Issued To Settle Royalty Agreement Value StockIssuedToSettleRoyaltyAgreementValue
CY2020Q1	gblx	Working Capital Deficit WorkingCapitalDeficit	3884877
CY2019Q1	gblx	Working Capital Deficit WorkingCapitalDeficit	3245409
CY2020Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2559914
CY2019Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1374771
CY2020Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	117967
CY2019Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	488329
CY2020Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	888012
CY2019Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	244931
CY2020Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	733557
CY2019Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1980015
CY2020Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	97271157
CY2019Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	93020015
CY2019	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	176471
CY2020	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	132914
CY2020Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	130378
CY2019Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	66748
CY2020	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	63630
CY2020	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	44371
CY2020	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1150995
CY2019	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	793820
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	128608852
CY2020Q1	us-gaap	Assets Assets	14352868
CY2019Q1	us-gaap	Assets Assets	30023302
CY2020Q1	us-gaap	Assets Current AssetsCurrent	7000880
CY2019Q1	us-gaap	Assets Current AssetsCurrent	3466771
CY2020Q1	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
CY2019Q1	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	1000387
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	151766
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	182055
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	182055
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	151766
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3579700
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	227758
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-30289
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3351942
CY2020	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	282835
CY2019	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	7248480
CY2020	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-260625
CY2019	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-9070409
CY2020	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-1244720
CY2019	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-1271177
CY2020Q1	us-gaap	Cash Uninsured Amount CashUninsuredAmount	0
CY2018Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	65883062
CY2019Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	99790989
CY2020Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	84538161
CY2020Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000
CY2019Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000
CY2018Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2018Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000
CY2019Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000
CY2018Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2020Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	275541602
CY2019Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	240627102
CY2020Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	275541602
CY2019Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	240627102
CY2020Q1	us-gaap	Common Stock Value CommonStockValue	27554
CY2019Q1	us-gaap	Common Stock Value CommonStockValue	24063
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	4002083
CY2019	us-gaap	Cost Of Revenue CostOfRevenue	3246097
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit
CY2020Q1	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	608580
CY2019Q1	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	799410
CY2020Q1	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	0
CY2019Q1	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	13928
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	510647
CY2020	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	525000
CY2019	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	4640971
CY2020	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	7583333
CY2019Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	175000
CY2019Q1	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	45703
CY2020	us-gaap	Disposal Group Not Discontinued Operation Loss Gain On Write Down DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown	4645054
CY2019	us-gaap	Disposal Group Not Discontinued Operation Loss Gain On Write Down DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
CY2020Q1	us-gaap	Due To Officers Or Stockholders Current DueToOfficersOrStockholdersCurrent	586512
CY2019Q1	us-gaap	Due To Officers Or Stockholders Current DueToOfficersOrStockholdersCurrent
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.05
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.11
CY2020	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	4393242
CY2019	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount
CY2020Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	14356170
CY2019Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	12495406
CY2020Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet
CY2019Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet
CY2020Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	10625357
CY2019Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	9960339
CY2020Q1	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	975461
CY2019Q1	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment
CY2020Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	2943816
CY2019Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	2883491
CY2020Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	136243
CY2019Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	68520
CY2020Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	14356170
CY2019Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	12495406
CY2020Q1	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	324707
CY2019Q1	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	416944
CY2020Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	91504
CY2019Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	230651
CY2020	us-gaap	Depreciation Depreciation	541462
CY2019	us-gaap	Depreciation Depreciation	338190
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	258729
CY2019	us-gaap	Depreciation And Amortization DepreciationAndAmortization	250187
CY2020Q1	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
CY2019Q1	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	14025372
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.024
CY2020Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	0
CY2020	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	426374
CY2020Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	3699859
CY2020Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	166769
CY2019Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	80132
CY2020Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	3533090
CY2019Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	3646540
CY2020Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	6639996
CY2020Q1	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	3781101
CY2020Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	581763
CY2020Q1	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	594767
CY2020Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	577444
CY2020Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	560625
CY2020Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	544296
CY2020Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	2940137
CY2020	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	252973
CY2020Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	12287
CY2019Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3745
CY2020Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1699966
CY2019Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1818802
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-216954
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt
CY2020	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	-178760
CY2019	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	-128946
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6483513
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13399524
CY2020	us-gaap	Gross Profit GrossProfit	-881463
CY2019	us-gaap	Gross Profit GrossProfit	208455
CY2020	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-11635465
CY2019	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-22025860
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11548628
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-21499715
CY2020	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-11635465
CY2019	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-22025860
CY2020	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.05
CY2019	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.10
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-1476220
CY2019	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-2654427
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
CY2019	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	-0.01
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	86837
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	526145
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1952653
CY2019	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	3420499
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-2178478
CY2019	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-4424959
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	22948
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	35590
CY2020	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	506145
CY2019	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	510647
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes
CY2019	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	510647
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	20000
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	781589
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1002846
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-412498
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-172895
CY2020	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-139147
CY2019	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-120089
CY2020	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	738435
CY2019	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties
CY2020	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	86837
CY2020Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	91465
CY2019	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	506145
CY2020	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	421055
CY2019	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	150845
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-665560
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	16971
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-51186
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-869210
CY2020	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	127059
CY2019	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense
CY2020	us-gaap	Interest Expense InterestExpense	1625204
CY2019	us-gaap	Interest Expense InterestExpense	4940090
CY2020	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	84354
CY2019	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	3464187
CY2020	us-gaap	Interest Paid Net InterestPaidNet	451040
CY2019	us-gaap	Interest Paid Net InterestPaidNet	539242
CY2020Q1	us-gaap	Interest Payable Current InterestPayableCurrent	397652
CY2019Q1	us-gaap	Interest Payable Current InterestPayableCurrent	142112
CY2020Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	466319
CY2019Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	579604
CY2020Q1	us-gaap	Inventory Gross InventoryGross	1724295
CY2019Q1	us-gaap	Inventory Gross InventoryGross	1696359
CY2020Q1	us-gaap	Inventory Net InventoryNet	1445839
CY2019Q1	us-gaap	Inventory Net InventoryNet	1533792
CY2019Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	440414
CY2020Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	278456
CY2019Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	162567
CY2020Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	1166511
CY2019Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	676341
CY2020Q1	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.17
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	39264
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	11779
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	3927
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	11779
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	11779
CY2020Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	9484
CY2020Q1	us-gaap	Liabilities Liabilities	14441362
CY2019Q1	us-gaap	Liabilities Liabilities	12867303
CY2020Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14352868
CY2019Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	30023302
CY2020Q1	us-gaap	Liabilities Current LiabilitiesCurrent	10885757
CY2019Q1	us-gaap	Liabilities Current LiabilitiesCurrent	6712180
CY2020Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
CY2019Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	2134277
CY2020Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
CY2019Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	2347511
CY2019Q1	us-gaap	Long Term Debt LongTermDebt	161072
CY2020Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable
CY2019Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	161072
CY2020Q1	us-gaap	Minority Interest MinorityInterest
CY2019Q1	us-gaap	Minority Interest MinorityInterest	8855757
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4988208
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	17500497
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	4705373
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	10252017
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-538784
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10996544
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-278159
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-1926135
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4479713
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9855895
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-3234993
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-8584718
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-23653165
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-12373579
CY2019	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1027122
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-738106
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-12373579
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-23653165
CY2020	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-11635465
CY2019	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-22025860
CY2020	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	-738114
CY2019	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	-1627305
CY2019	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	1500000
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	790225
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	11402464
CY2020	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	480000
CY2019	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit
CY2020	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	16000
CY2019Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	300000
CY2020Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	22515
CY2019Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent
CY2020Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	26685
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset
CY2020	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	47695
CY2020	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt">Reclassifications</div></div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Certain reclassifications have been made to the comparative period amounts in order to conform to the current period presentation. The current and long-term capital lease obligations recorded in the consolidated balance sheet as of <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2019 </div>have been reclassified to conform to the current period presentation as finance lease obligations, current, and finance lease obligations, long term. Certain items on the statements of cash flows have been reclassified to confirm with current period presentation. In addition, the assets, liabilities, income, and cash flows of GB Sciences Louisiana, LLC have been separated from the comparative period amounts to confirm to the current period presentation as discontinued operations as the result of the sale of the Company's interest in GB Sciences Louisiana, LLC (Note <div style="display: inline; font-style: italic; font: inherit;">15</div>). The reclassifications had <div style="display: inline; font-style: italic; font: inherit;">no</div> effect on the reported financial position, results of operations or cash flows of the Company.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div>
CY2020	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	2630000
CY2020Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	50596940
CY2019Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	47430184
CY2019	us-gaap	Other Expenses OtherExpenses	3140925
CY2020	us-gaap	Other Noncash Expense OtherNoncashExpense
CY2019	us-gaap	Other Noncash Expense OtherNoncashExpense	2140925
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-194248
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3368556
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	175000
CY2019	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts
CY2020	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	188593
CY2019	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	959620
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	91862
CY2020	us-gaap	Noncontrolling Interest Decrease From Deconsolidation NoncontrollingInterestDecreaseFromDeconsolidation	8707651
CY2019	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	6999889
CY2020	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	590000
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	461402
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-8308646
CY2020Q1	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	5224423
CY2019Q1	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent
CY2020Q1	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	91504
CY2019Q1	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	230651
CY2020Q1	us-gaap	Notes Payable Current NotesPayableCurrent	5534728
CY2019Q1	us-gaap	Notes Payable Current NotesPayableCurrent	2229812
CY2020Q1	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	151923
CY2019Q1	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-12010030
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-13191069
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	75306
CY2020Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	29780
CY2020Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7265
CY2019Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent
CY2019	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	414041
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	202297
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1512094
CY2020Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	60885
CY2019Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	262208
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	13033334
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	12583334
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10983334
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.28
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.28
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.28
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	10983334
CY2019	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment
CY2020	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1274790
CY2019	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises
CY2020	us-gaap	Profit Loss ProfitLoss	-13111685
CY2019	us-gaap	Profit Loss ProfitLoss	-24680287
CY2020Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6267390
CY2019Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12461721
CY2020Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5533833
CY2019Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10481706
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	108001
CY2019	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	5849
CY2020	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	106049
CY2019	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	690827
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1543397
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	458790
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	287260
CY2020Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-97387205
CY2019Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-84743836
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.27
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	1966388
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	9450333
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	10983334
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.28
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	850000
CY2020	us-gaap	Revenues Revenues	3120620
CY2019	us-gaap	Revenues Revenues	3454552
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1600000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	400000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2646723
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	43000
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	0.28
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.24
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.41
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y76D
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y65D
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y7D
CY2020Q1	us-gaap	Short Term Investments ShortTermInvestments	0
CY2020	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	2100000
CY2019	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	4032407
CY2019Q4	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	2000000
CY2020	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	7668167
CY2019	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised
CY2019	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	4640971
CY2020	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	525000
CY2019	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	1254363
CY2020	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	214000
CY2019	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	6522125
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	718696
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	-88494
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	8300242
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-88494
CY2019Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	17155999
CY2018Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	15631721
CY2020Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	592982
CY2019Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	506145
CY2018Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	86837
CY2020	us-gaap	Use Of Estimates UseOfEstimates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to allowances for doubtful accounts, inventory valuation and standard cost allocations, valuation of initial right-of-use assets and corresponding lease liabilities, valuation of beneficial conversion features in convertible debt, valuation of the assets and liabilities of discontinued operations, stock-based compensation expense, purchased intangible asset valuations, deferred income tax asset valuation allowances, uncertain tax positions, litigation, other loss contingencies, and impairment of long lived assets.  These estimates and assumptions are based on current facts, historical experience and various other factors that the Company believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of costs and expenses that are <div style="display: inline; font-style: italic; font: inherit;">not</div> readily apparent from other sources. The actual results the Company experiences <div style="display: inline; font-style: italic; font: inherit;"> may </div>differ materially and adversely from these estimates.</div></div></div></div></div>
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	258450641
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	209537769

Files In Submission

Name	View Source	Status
0001437749-20-018953-index-headers.html	Edgar Link	pending
0001437749-20-018953-index.html	Edgar Link	pending
0001437749-20-018953.txt	Edgar Link	pending
0001437749-20-018953-xbrl.zip	Edgar Link	pending
ex_187208.htm	Edgar Link	pending
ex_187209.htm	Edgar Link	pending
ex_187210.htm	Edgar Link	pending
ex_187211.htm	Edgar Link	pending
ex_187212.htm	Edgar Link	pending
ex_198533.htm	Edgar Link	pending
ex_198548.htm	Edgar Link	pending
ex_198593.htm	Edgar Link	pending
ex_198595.htm	Edgar Link	pending
ex_198656.htm	Edgar Link	pending
ex_198685.htm	Edgar Link	pending
ex_198687.htm	Edgar Link	pending
ex_198693.htm	Edgar Link	pending
ex_198694.htm	Edgar Link	pending
ex_198701.htm	Edgar Link	pending
ex_199371.htm	Edgar Link	pending
ex_199384.htm	Edgar Link	pending
ex_199384img001.jpg	Edgar Link	pending
ex_199384img002.jpg	Edgar Link	pending
ex_199384img003.jpg	Edgar Link	pending
ex_199384img004.jpg	Edgar Link	pending
ex_199384img005.jpg	Edgar Link	pending
ex_199385.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
gblx-20200331.xml	Edgar Link	completed
gblx-20200331.xsd	Edgar Link	pending
gblx-20200331_cal.xml	Edgar Link	unprocessable
gblx-20200331_def.xml	Edgar Link	unprocessable
gblx-20200331_lab.xml	Edgar Link	unprocessable
gblx-20200331_pre.xml	Edgar Link	unprocessable
gblx20200331_10k.htm	Edgar Link	pending
p1.jpg	Edgar Link	pending
p2.jpg	Edgar Link	pending
p3.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
z3azwbvyh10kimg001.jpg	Edgar Link	pending
zwy5horm510kimg001.jpg	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GBLX
GB SCIENCES INC Stock $gblx

2020 Q3 Form 10-K Financial Statement

#000143774920018953 Filed on August 28, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GBLX GB SCIENCES INC Stock $gblx

2020 Q3 Form 10-K Financial Statement

#000143774920018953 Filed on August 28, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GBLX
GB SCIENCES INC Stock $gblx